Hikma Pharmaceuticals PLC - ESG Rating & Company Profile powered by AI
This assessment of Hikma Pharmaceuticals PLC was prepared by All Street Sevva using cutting edge NLP. Other corporations in the scoring industry group for Hikma Pharmaceuticals PLC are shown below. The webpage includes a Q&A table on Hikma Pharmaceuticals PLC.
Hikma Pharmaceuticals PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Hikma Pharmaceuticals PLC | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Hikma Pharmaceuticals PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC report the average age of the workforce?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC offer flexible work?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC conduct supply chain audits?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose water use targets?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Hikma Pharmaceuticals PLC have a product recall in the last two years?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Hikma Pharmaceuticals PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose parental leave metrics?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Hikma Pharmaceuticals PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose its waste policy?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC report according to TCFD requirements?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose energy use targets?
Sign up for free to unlockDoes Hikma Pharmaceuticals PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Hikma Pharmaceuticals PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Hikma Pharmaceuticals PLC
These potential risks are based on the size, segment and geographies of the company.
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.